FSSAI Food Labelling and Display Regulations and Updates

FSSAI Advisory 2026: Ashwagandha Leaves Banned in Food Products – Complete Compliance Guide

April 16, 2026 4 Min Read

Introduction

In April 2026, the Food Safety and Standards Authority of India (FSSAI) issued a critical regulatory advisory that directly impacts manufacturers of nutraceuticals, health supplements, and functional foods.

The advisory clarifies a long-standing ambiguity:
Ashwagandha leaves are NOT permitted in food products in India.

While many brands have been using different parts of the Ashwagandha plant, this update makes it clear that only specific parts are legally allowed.

If you’re a food business operator (FBO), ignoring this update could lead to regulatory action, product recalls, or penalties.

This guide breaks down everything you need to know — in plain English.

What Is the FSSAI Advisory About?

The FSSAI advisory (dated April 16, 2026) addresses the use of Ashwagandha (Withania somnifera) in food products.

Key clarification:

Only Ashwagandha roots and their extracts are permitted
Leaves are strictly not allowed in any form:
- Crude
- Powder
- Extract
- Any derivative

This applies across:

Health supplements
Nutraceuticals
Functional foods
Foods for special dietary use

The advisory was issued after it was observed that several manufacturers were still using Ashwagandha leaves, despite existing regulations.

Is This Advisory Mandatory or Optional?

Let’s address the confusion directly.

Short answer: It is mandatory in practice.

Even though the document is titled an “advisory,” it clearly states:

The use of Ashwagandha leaves is not permitted under current regulations
Non-compliance will attract action under the Food Safety and Standards Act, 2006

Additionally:

State authorities have been instructed to monitor and enforce compliance
Licensing authorities are expected to take action against violations

That means this is not a suggestion — it’s enforceable.

Why Are Ashwagandha Leaves Banned?

This isn’t arbitrary. There’s a strong scientific and regulatory basis behind it.

1. Safety Concerns

Studies have shown that Ashwagandha leaves may contain:

Higher concentrations of Withaferin-A
Other reactive withanolides

These compounds may pose potential health risks when consumed in certain forms or quantities.

2. AYUSH Recommendation

The Ministry of AYUSH has clearly directed:

Use only Ashwagandha roots
Leaves are strictly prohibited

This is based on:

Traditional usage systems (Ayurveda)
Updated safety dossiers (2024 review)

3. Regulatory Alignment

FSSAI regulations (Schedule IV) already specify:

Permitted plant parts for use in food products

The advisory simply:
✔ Reinforces existing law
✔ Closes misuse gaps
✔ Aligns food and AYUSH regulations

What Does the Law Actually Allow?

✅ Allowed:

Ashwagandha roots
Root extracts

❌ Not Allowed:

Leaves
Leaf extracts
Whole plant (if leaves included)
Any formulation containing leaf derivatives

Who Is Affected by This Regulation?

This advisory impacts a wide range of businesses:

1. Nutraceutical Brands

Capsules
Tablets
Herbal blends

2. Functional Food Companies

Health drinks
Protein mixes
Wellness powders

3. D2C Wellness Startups

Adaptogen blends
Stress-relief products

4. Contract Manufacturers

Private label supplement manufacturers

What Happens If You Ignore This?

Let’s be very clear — this is where most brands underestimate the risk.

Possible consequences:

Product rejection during approval
Mandatory product reformulation
Product recalls from market
Financial penalties
License suspension or cancellation

And more importantly:
Loss of trust with distributors and marketplaces (Amazon, Flipkart, etc.)

How to Ensure Compliance (Step-by-Step)

Here’s a practical checklist you can follow immediately:

Step 1: Audit Your Ingredients

Check if any product uses:
- Ashwagandha leaves
- Leaf extracts
- Mixed plant powders

Step 2: Verify Supplier Documentation

Ask suppliers:
- Which plant part is used?
- Do they have COA (Certificate of Analysis)?

Step 3: Reformulate If Needed

If leaves are present:

Replace with root extract
Ensure dosage complies with FSSAI limits

Step 4: Update Labeling

Clearly mention:
- “Ashwagandha Root Extract”
Avoid vague terms like:
- “Ashwagandha Extract” (without specifying part)

Step 5: Maintain Documentation

Keep ready:

Ingredient specs
Lab reports
Supplier declarations

Common Mistakes to Avoid

1. Using generic ingredient names

Example: “Ashwagandha Extract”
→ Not acceptable without specifying plant part

2. Assuming herbal = safe

Natural ingredients still need regulatory approval

3. Copying competitor labels

Many brands are non-compliant without realizing it

4. Ignoring advisory updates

Regulations evolve — staying updated is critical

How This Impacts Label Compliance

This advisory highlights a deeper issue:

👉 Ingredient compliance is just as important as label formatting

Even if your label looks perfect:

Wrong ingredient = non-compliant product

This is exactly where most brands fail.

How LabelVeda Can Help

If you’re building or selling food products, manual compliance checks are risky and time-consuming.

LabelVeda helps you:

✅ Detect non-permitted ingredients instantly
✅ Validate label compliance as per FSSAI
✅ Avoid costly mistakes before printing
✅ Stay updated with latest advisories

Try it before your next product launch

Don’t wait for a rejection or penalty.

Run your label through LabelVeda and catch compliance issues in seconds.

Final Thoughts

The 2026 FSSAI advisory on Ashwagandha is a wake-up call for the industry.

It reinforces a simple rule:

Not all parts of a plant are allowed — and using the wrong one can cost you your business.

If your product contains Ashwagandha:

Stick to roots only
Avoid leaves completely
Document everything

Because in food compliance:
👉 Assumptions are expensive. Accuracy is everything.

Tags: